scPharmaceuticals grabs $45.6 mln Series B
Lexington, Massachusetts-based scPharmaceuticals, Inc, a biopharmaceutical company that is developing drugs for subcutaneous delivery, has raised $45.6 million in Series B funding. OrbiMed and a Sun Pharma subsidiary led the round with participation from return backers 5AM Ventures and Lundbeckfond Ventures.
4 January 2017•1 min read
